NHNKF Stock - Nihon Kohden Corporation
Unlock GoAI Insights for NHNKF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $225.42B | $221.99B | $206.60B | $205.13B | $199.73B |
| Gross Profit | $117.16B | $111.35B | $105.93B | $109.09B | $102.23B |
| Gross Margin | 52.0% | 50.2% | 51.3% | 53.2% | 51.2% |
| Operating Income | $20.71B | $19.59B | $21.12B | $30.99B | $27.09B |
| Net Income | $14.10B | $17.03B | $17.11B | $23.43B | $18.24B |
| Net Margin | 6.3% | 7.7% | 8.3% | 11.4% | 9.1% |
| EPS | $84.88 | $101.23 | $203.28 | $276.50 | $214.21 |
Nihon Kohden Corporation engages in research and development, production, sale, repair, and maintenance of medical electronic equipment in Japan, Americas, Europe, rest of Asia, and internationally. The company offers physiological measuring equipment, including electroencephalographs, electrocardiographs, evoked potential and electromyogram measuring instruments, and polygraphs for cath labs, as well as diagnostic information systems and related consumables, such as recording papers, electrodes and catheters, and maintenance services. It also provides patient monitors systems comprising central monitors, bedside monitors, wireless monitors, remote access software, and other equipment; and clinical information systems and related consumables, such as electrodes and sensors. In addition, the company offers treatment equipment, which include defibrillators, automated external defibrillators (AED), ventilators, pacemakers, anesthesia machines, cochlear implants, and related consumables and services, which include AED pads and batteries; and other medical equipment, including hematology and clinical chemistry analyzers, ultrasound diagnostic equipment, and equipment for research and others, as well as consumables, including test reagents, and installation and maintenance services. Additionally, it engages in insurance brokerage and technology licensing business. The company was incorporated in 1951 and is headquartered in Shinjuku, Japan.
Visit WebsiteEarnings History & Surprises
NHNKFEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 5, 2026 | — | — | — | — |
Q4 2025 | Nov 10, 2025 | $0.16 | $0.00 | -99.2% | ✗ MISS |
Q3 2025 | Aug 6, 2025 | $0.02 | $0.01 | -65.7% | ✗ MISS |
Q2 2025 | May 13, 2025 | $0.29 | $0.25 | -14.8% | ✗ MISS |
Q1 2025 | Feb 5, 2025 | $0.14 | $0.29 | +111.3% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $0.04 | $-0.01 | -129.8% | ✗ MISS |
Q3 2024 | Aug 2, 2024 | $0.02 | $0.03 | +14.2% | ✓ BEAT |
Q2 2024 | May 13, 2024 | $0.29 | $0.36 | +23.7% | ✓ BEAT |
Q1 2024 | Feb 2, 2024 | $0.13 | $-0.01 | -104.7% | ✗ MISS |
Q3 2023 | Sep 30, 2023 | $0.14 | $0.33 | +137.1% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.10 | $0.31 | +215.2% | ✓ BEAT |
Q1 2023 | Mar 31, 2023 | $0.25 | $0.74 | +195.3% | ✓ BEAT |
Q1 2023 | Feb 2, 2023 | $0.14 | $0.03 | -79.5% | ✗ MISS |
Q4 2022 | Nov 9, 2022 | $0.15 | $0.41 | +163.1% | ✓ BEAT |
Q3 2022 | Aug 3, 2022 | $0.13 | $0.33 | +146.4% | ✓ BEAT |
Q2 2022 | May 13, 2022 | $0.41 | $0.60 | +45.2% | ✓ BEAT |
Q1 2022 | Feb 2, 2022 | $0.42 | $0.47 | +13.2% | ✓ BEAT |
Q4 2021 | Nov 8, 2021 | $0.83 | $0.80 | -3.6% | ✗ MISS |
Q3 2021 | Aug 4, 2021 | $0.12 | $0.49 | +318.8% | ✓ BEAT |
Latest News
Frequently Asked Questions about NHNKF
What is NHNKF's current stock price?
What is the analyst price target for NHNKF?
What sector is Nihon Kohden Corporation in?
What is NHNKF's market cap?
Does NHNKF pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to NHNKF for comparison